Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Schuuring

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 4, 2023
Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancerMirte Muller, Myron G Best, Vincent van der Noort, et al.
International Journal of Surgical Pathology|January 29, 2026
Radiotherapy Response Prediction in Myxofibrosarcomas and Undifferentiated Soft Tissue Sarcomas Using DNA Methylation and Copy Number ProfilingTony G Kleijn, Baptiste Ameline, Wierd Kooistra, et al.
The Lancet Regional Health. Europe|March 13, 2024
Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countriesVincent D de Jager, Wim Timens, Arnaud Bayle, et al.
Frontiers in Oncology|February 11, 2020
Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing ComplexityDaan van den Broek, T Jeroen N Hiltermann, Bonne Biesma, et al.
Virchows Archiv : an International Journal of Pathology|October 1, 2024
Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular PathologyMarius Ilié, Vivien Lake, Enrique de Alava, et al.
The Journal of Pathology. Clinical Research|March 7, 2025
Costs of biomarker testing in advanced non-small cell lung cancer: a global study comparing next-generation sequencing and single-gene testingUmberto Malapelle, Chien-Chin Chen, Enrique de Álava, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2020
First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced CancersFenne L Komdeur, Amrita Singh, Stephanie van de Wall, et al.
Clinical Chemistry|March 14, 2024
External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN ConsortiumPaul van der Leest, Pim Rozendal, John Hinrichs, et al.
Clinical Chemistry|May 26, 2022
Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor ProfilingPaul van der Leest, Emma M Ketelaar, Carel J M van Noesel, et al.
Clinical Chemistry|October 20, 2019
Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work FlowsRita Lampignano, Martin H D Neumann, Sabrina Weber, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 4, 2023
Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancerMirte Muller, Myron G Best, Vincent van der Noort, et al.
International Journal of Surgical Pathology|January 29, 2026
Radiotherapy Response Prediction in Myxofibrosarcomas and Undifferentiated Soft Tissue Sarcomas Using DNA Methylation and Copy Number ProfilingTony G Kleijn, Baptiste Ameline, Wierd Kooistra, et al.
The Lancet Regional Health. Europe|March 13, 2024
Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countriesVincent D de Jager, Wim Timens, Arnaud Bayle, et al.
Frontiers in Oncology|February 11, 2020
Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing ComplexityDaan van den Broek, T Jeroen N Hiltermann, Bonne Biesma, et al.
Virchows Archiv : an International Journal of Pathology|October 1, 2024
Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular PathologyMarius Ilié, Vivien Lake, Enrique de Alava, et al.
The Journal of Pathology. Clinical Research|March 7, 2025
Costs of biomarker testing in advanced non-small cell lung cancer: a global study comparing next-generation sequencing and single-gene testingUmberto Malapelle, Chien-Chin Chen, Enrique de Álava, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2020
First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced CancersFenne L Komdeur, Amrita Singh, Stephanie van de Wall, et al.
Clinical Chemistry|March 14, 2024
External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN ConsortiumPaul van der Leest, Pim Rozendal, John Hinrichs, et al.
Clinical Chemistry|May 26, 2022
Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor ProfilingPaul van der Leest, Emma M Ketelaar, Carel J M van Noesel, et al.
Clinical Chemistry|October 20, 2019
Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work FlowsRita Lampignano, Martin H D Neumann, Sabrina Weber, et al.
Pageof 21